Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
EPIC: ALNY
Market: NASDAQ
52-week High/Low: $138.73 / $53.71
Sector: Pharmaceuticals
Market Cap: $10,964.30M
Website: www.alnylam.com
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). The RNAi therapeutic program, ALN-RSV01, is in Phase II clinical trials for the treatment of human respiratory syncytial virus (RSV), infection.

Deal ALNY Tax Free* Losses can exceed
your initial deposit
*subject to change and depends on individual circumstances.

Alnylam Pharmaceuticals

www.alnylam.com

Interactive graph

col 3
col 4
col 5
col 6

Alnylam Pharmaceuticals RNS announcements

Sorry, there are no rns announcements by this company.

© Proactive Investors 2015